Furthermore, Kaplan-Meier survival analysis demonstrated that NSCLC patients with positive ALDH1 expression had significantly reduced survival compared with that of those negative for ALDH1. This evidence concerns the gene ALDH1A1 and non-small cell lung carcinoma.